These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22077420)

  • 1. The antimicrobial effect of Iseganan HCl oral solution in patients receiving stomatotoxic chemotherapy: analysis from a multicenter, double-blind, placebo-controlled, randomized, phase III clinical trial.
    Elad S; Epstein JB; Raber-Durlacher J; Donnelly P; Strahilevitz J
    J Oral Pathol Med; 2012 Mar; 41(3):229-34. PubMed ID: 22077420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial).
    Giles FJ; Miller CB; Hurd DD; Wingard JR; Fleming TR; Sonis ST; Bradford WZ; Pulliam JG; Anaissie EJ; Beveridge RA; Brunvand MM; Martin PJ;
    Leuk Lymphoma; 2003 Jul; 44(7):1165-72. PubMed ID: 12916869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy.
    Giles FJ; Rodriguez R; Weisdorf D; Wingard JR; Martin PJ; Fleming TR; Goldberg SL; Anaissie EJ; Bolwell BJ; Chao NJ; Shea TC; Brunvand MM; Vaughan W; Petersen F; Schubert M; Lazarus HM; Maziarz RT; Silverman M; Beveridge RA; Redman R; Pulliam JG; Devitt-Risse P; Fuchs HJ; Hurd DD
    Leuk Res; 2004 Jun; 28(6):559-65. PubMed ID: 15120931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy.
    Trotti A; Garden A; Warde P; Symonds P; Langer C; Redman R; Pajak TF; Fleming TR; Henke M; Bourhis J; Rosenthal DI; Junor E; Cmelak A; Sheehan F; Pulliam J; Devitt-Risse P; Fuchs H; Chambers M; O'Sullivan B; Ang KK
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):674-81. PubMed ID: 14967419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iseganan HCl: a novel antimicrobial agent.
    Giles FJ; Redman R; Yazji S; Bellm L
    Expert Opin Investig Drugs; 2002 Aug; 11(8):1161-70. PubMed ID: 12150709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia.
    Kollef M; Pittet D; Sánchez García M; Chastre J; Fagon JY; Bonten M; Hyzy R; Fleming TR; Fuchs H; Bellm L; Mercat A; Mañez R; Martínez A; Eggimann P; Daguerre M; Luyt CE;
    Am J Respir Crit Care Med; 2006 Jan; 173(1):91-7. PubMed ID: 16192451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial.
    Ferretti GA; Raybould TP; Brown AT; Macdonald JS; Greenwood M; Maruyama Y; Geil J; Lillich TT; Ash RC
    Oral Surg Oral Med Oral Pathol; 1990 Mar; 69(3):331-8. PubMed ID: 2179802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do cancer patients with chemotherapy-induced leukopenia benefit from an antiseptic chlorhexidine-based oral rinse? A double-blind, block-randomized, controlled study.
    Pitten FA; Kiefer T; Buth C; Doelken G; Kramer A
    J Hosp Infect; 2003 Apr; 53(4):283-91. PubMed ID: 12660125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy.
    Limaye SA; Haddad RI; Cilli F; Sonis ST; Colevas AD; Brennan MT; Hu KS; Murphy BA
    Cancer; 2013 Dec; 119(24):4268-76. PubMed ID: 24114811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of mouth rinses and dentifrice-containing magnesium monoperoxyphthalate (mmpp) on oral microflora, plaque reduction, and mucosa.
    Scully C; El-Kabir M; Greenman J; Porter SR; Mutlu S; Barton I; Adair R
    J Clin Periodontol; 1999 Apr; 26(4):234-8. PubMed ID: 10223394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical study to assess the 12-hour antimicrobial effects of cetylpyridinium chloride mouthwashes on supragingival plaque bacteria.
    He S; Wei Y; Fan X; Hu D; Sreenivasan PK
    J Clin Dent; 2011; 22(6):195-9. PubMed ID: 22403975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy of a 0.07% cetylpyridinium chloride mouth rinse in relation to plaque and gingivitis: a 6-month randomized, vehicle-controlled clinical trial.
    Van Leeuwen MP; Rosema NA; Versteeg PA; Slot DE; Van Winkelhoff AJ; Van der Weijden GA
    Int J Dent Hyg; 2015 May; 13(2):93-103. PubMed ID: 25040299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled, randomized trial to evaluate the role of tetrachlorodecaoxide in the management of chemotherapy-induced oral mucositis.
    Malik IA; Moid I; Haq S; Sabih M
    J Pain Symptom Manage; 1997 Aug; 14(2):82-7. PubMed ID: 9262037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of use of 0.05% cetylpyridinium chloride mouthwash on normal oral flora.
    Radford JR; Beighton D; Nugent Z; Jackson RJ
    J Dent; 1997 Jan; 25(1):35-40. PubMed ID: 9080738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial therapy to prevent or treat oral mucositis.
    Donnelly JP; Bellm LA; Epstein JB; Sonis ST; Symonds RP
    Lancet Infect Dis; 2003 Jul; 3(7):405-12. PubMed ID: 12837345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Epstein JB; Silverman S; Paggiarino DA; Crockett S; Schubert MM; Senzer NN; Lockhart PB; Gallagher MJ; Peterson DE; Leveque FG
    Cancer; 2001 Aug; 92(4):875-85. PubMed ID: 11550161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iseganan (IntraBiotics pharmaceuticals).
    Toney JH
    Curr Opin Investig Drugs; 2002 Feb; 3(2):225-8. PubMed ID: 12020050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse.
    Weisdorf DJ; Bostrom B; Raether D; Mattingly M; Walker P; Pihlstrom B; Ferrieri P; Haake R; Goldman A; Woods W
    Bone Marrow Transplant; 1989 Jan; 4(1):89-95. PubMed ID: 2647192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized DoubleBlind PlaceboControlled Trial of Propolis for Oral Mucositis in Patients Receiving Chemotherapy for Head and Neck Cancer.
    AkhavanKarbassi MH; Yazdi MF; Ahadian H; SadrAbad MJ
    Asian Pac J Cancer Prev; 2016; 17(7):3611-4. PubMed ID: 27510017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical transforming growth factor-beta3 in the prevention or alleviation of chemotherapy-induced oral mucositis in patients with lymphomas or solid tumors.
    Foncuberta MC; Cagnoni PJ; Brandts CH; Mandanas R; Fields K; Derigs HG; Reed E; Sonis ST; Fay J; LeVeque F; Pouillart P; Schrezenmeier H; Emmons R; Thiel E;
    J Immunother; 2001; 24(4):384-8. PubMed ID: 11565840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.